Medicare Enrolled
Dr. Mark Juska, M.D.
Physical Medicine & Rehabilitation · Muskegon, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Juska from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Juska?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Juska
Dr. Mark Juska is a physical medicine & rehabilitation specialist in Muskegon, MI, with 17 years of NPI registration. Based on federal Medicare data, Dr. Juska performed 13,967 Medicare services across 1,185 unique beneficiaries.
Between the years covered by Open Payments, Dr. Juska received a total of $7,038 from 39 pharmaceutical and/or device companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in physical medicine & rehabilitation. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Juska is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 2% volume in MI
$7,038 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,967
Medicare services
Top 2% in MI for physical medicine & rehabilitation
1,185
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~822 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Joint lubricant injection (Gel-Syn) An injection of hyaluronan or its derivative into a joint space to supplement joint fluid. |
9,577 | $0 | $4 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,874 | $0 | $10 |
| Injection, fentanyl citrate, 0.1 mg | 655 | $1 | $2 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
274 | $0 | $14 |
| Injection, methylprednisolone acetate, 40 mg | 228 | $6 | $16 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
209 | $0 | $8 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
171 | $62 | $217 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
134 | $55 | $230 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
129 | $144 | $660 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
102 | $216 | $968 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
78 | $79 | $272 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
67 | $37 | $121 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
62 | $451 | $1,921 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
60 | $176 | $624 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
56 | $257 | $1,040 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
52 | $9 | $15 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
43 | $181 | $630 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
28 | $182 | $792 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $38 | $135 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
26 | $101 | $426 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
26 | $92 | $305 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
22 | $37 | $128 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
20 | $114 | $402 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
18 | $437 | $1,817 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
18 | $259 | $1,043 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $80 | $271 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,038
Total received (2018-2024)
Avg $1,005/year across 7 years
Top 5% in MI for physical medicine & rehabilitation
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
224
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,611 (65.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$2,427 (34.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$686
2023
$590
2022
$703
2021
$672
2020
$193
2019
$3,603
2018
$592
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$347
Nevro Corp.
$88
SPR Therapeutics, Inc
$62
Collegium Pharmaceutical, Inc.
$57
Teva Pharmaceuticals USA, Inc.
$37
PFIZER INC.
$24
Medtronic, Inc.
$20
Nalu Medical, Inc.
$19
Spinal Simplicity, LLC
$18
Curonix LLC
$14
Top 3 companies account for 72.5% of 2024 payments
All-time payments by company (2018-2024) ›
Arthrex, Inc.
$2,427
Abbott Laboratories
$963
Nevro Corp.
$566
Medwest Associates
$363
Supernus Pharmaceuticals, Inc.
$299
Collegium Pharmaceutical, Inc.
$286
PFIZER INC.
$186
BOSTON SCIENTIFIC CORPORATION
$182
Teva Pharmaceuticals USA, Inc.
$150
Amgen Inc.
$140
Medtronic, Inc.
$128
Biohaven Pharmaceutical Holding Company Ltd.
$120
ASSERTIO THERAPEUTICS, Inc.
$110
Allergan Inc.
$97
Novartis Pharmaceuticals Corporation
$81
GRT US Holding, Inc.
$78
SI-BONE, Inc.
$77
ABBVIE INC.
$73
Flexion Therapeutics, Inc.
$70
SPR Therapeutics, Inc
$62
Boston Scientific Corporation
$60
Vertiflex, Inc.
$58
Nalu Medical, Inc.
$57
Biohaven Pharmaceuticals, Inc.
$52
Vertical Pharmaceuticals, LLC
$40
Assertio Therapeutics, Inc.
$34
SI-BONE, INC.
$33
BioDelivery Sciences International, Inc.
$32
Medtronic USA, Inc.
$30
Bioventus LLC
$25
RTI Surgical, Inc.
$24
Kaleo, Inc.
$24
Fidia Pharma USA Inc.
$19
Pacira Therapeutics, Inc.
$19
AbbVie Inc.
$18
Spinal Simplicity, LLC
$18
Curonix LLC
$14
Pacira Pharmaceuticals Incorporated
$12
DePuy Synthes Sales Inc.
$12
Top 3 companies account for 56.2% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · Aimovig · Allograft · BELBUCA · BOTOX · BOTOX THERAPEUTIC · Belbuca · COMIRNATY · Cambia · Durolane · ETERNA · EVENITY · Evzio · GELSYN 3 · GENERAL THERAPIES · Gralise · HA MINUTEMAN G3-R · HYMOVIS · IFUSE IMPLANT · INTELLIS ADAPTIVESTIM · Iovera System · LORZONE · LYRICA · MONOVISC · NT1100 NT2000iX Simplicity · NURTEC ODT · Nalu Neurostimulation System · Omnia · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · Qutenza · SPECIFY · SPECTRA WAVEWRITER · SPRINT PNS System · Senza · Senza Spinal Cord Stimulation System · Superion ISS · TROKENDI XR · UBRELVY · WAVEWRITER ALPHA · XTAMPZA · XTAMPZAER · Xtampza ER · ZIPSOR · Zilretta · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (66%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for physical medicine & rehabilitation in MI.
Geographic Context
Physical medicine & rehabilitations within 10 mi
18
Per 100K population
10.3
County median income
$63,495
Nearest hospital
TRINITY HEALTH MUSKEGON HOSPITAL
4.4 mi
4.4 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Juska is a mixed practice specialist, with above-average Medicare volume (top 2% in MI), with low-engagement industry engagement in the top 5% of MI peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Juska experienced with joint lubricant injection (gel-syn)?
Based on Medicare claims data, Dr. Juska performed 9,577 joint lubricant injection (gel-syn) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Juska receive payments from pharmaceutical companies?
Yes. Dr. Juska received a total of $7,038 from 39 companies across 224 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Juska's costs compare to other physical medicine & rehabilitations in Muskegon?
Dr. Juska's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Juska) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Physical Medicine & Rehabilitation
Common procedures, typical costs, and what industry payments mean in physical medicine & rehabilitation.
Same specialty & city
Physical Medicine & Rehabilitations in Muskegon
Browse physical medicine & rehabilitations in Muskegon ranked by procedure volume and transparency data.
Highest volume
Top Physical Medicine & Rehabilitations in MI
Physical medicine & rehabilitations ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Physical Medicine & Rehabilitations in MI
Which MI physical medicine & rehabilitations receive the most from drug and device companies.
By company
Arthrex, Inc. Payments to Doctors
See all physicians who received payments from Arthrex, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology